This technology is a targeted approach to modulate neuroproteasome activity, enabling precise regulation of Tau aggregation in Alzheimer’s disease and related neurodegenerative disorders.
This technology is a biologic platform that enhances SUMO2 conjugation to preserve or restore synaptic function and memory in Alzheimer’s disease (AD) without altering amyloid burden.
This technology is a deep learning platform that uses curriculum learning-based strategies to train neural networks for real-time optimization of beamforming, thus improving communication in 5G and wireless networks.
